Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients

Launched by QILU HOSPITAL OF SHANDONG UNIVERSITY · Nov 21, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a new type of rehabilitation called Virtual Reality Task Oriented Training (VR-TOT) on improving arm function in stroke patients. Stroke can lead to weakness or paralysis on one side of the body, making daily activities very challenging. This study aims to see if using virtual reality, which provides engaging and motivating environments for practice, can help patients recover better than traditional therapy methods.

To participate in the trial, individuals must be between 18 and 80 years old and have experienced their first stroke within the last 1 to 6 months. They should have some ability to move their affected arm and be able to understand and follow simple instructions. Throughout the study, participants will take part in various assessments to measure their improvement in arm function and overall well-being. It's important to note that those with certain medical conditions or past strokes may not be eligible. If you or a loved one is interested, this trial could offer a promising new approach to recovery after a stroke.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • -1. Ischemic or hemorrhagic stroke was diagnosed based on the history, symptoms, and signs combined with CT or MRI imaging; 2. First stroke, onset time from 1 to 6 months, age ≥ 18 - 80 years ; 3. Hemiplegia, Brunnstrom stage \> Ⅰ, modified Ashworth grade \< 4; 4. Patients can sit and stand for upper limb function assessment and rehabilitation training; 5. No severe cognitive impairment, MMSE \> 17, able to accurately understand the questionnaire questions and scoring criteria, and complete the body drift test; No history of serious mental illness; 6. No obvious abnormality in visual acuity or corrected visual acuity; There was no obvious abnormality in hearing. There was no sensory aphasia or unilateral neglect.
• • 7. Patients or their family members signed informed consent to participate in the experiment.
• Exclusion Criteria:
• • 1. Previous history of stroke, traumatic or non-vascular encephalopathy; 2. Skull defect or allogeneic repair; 3. combined with other neurological and mental diseases; 4. Previous diseases that may cause upper limb motor/sensory dysfunction, such as neck tumor or radiotherapy and chemotherapy history, cervical spondylosis, cervical spine or upper limb fracture history, traumatic brachial plexus injury history, arthritis, diabetes mellitus, myasthenia gravis, multiple sclerosis, etc.
• • 5. Accompanied by obvious vertigo or dizziness symptoms or related diseases (such as motion sickness, Meniere's syndrome, otolithiasis, etc.); 6. Accompanied by obvious pain; 7. Evidence of ataxia and cerebellar or brainstem lesions according to the NIHSS; 8. Ongoing participation in other clinical investigators; 9. Unstable condition, refusal to sign the informed consent, and unwillingness to cooperate with the examination and treatment.